logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Shockwave Medical Announces Agreement To Acquire Neovasc

Jan 17, 2023•almost 3 years ago

Acquiring Company

ShockWave Medical, Inc.

Acquired Company

Neovasc

Santa ClaraTherapeuticsMedical DeviceMedicalBiotechnologyHealth CareManufacturingBiotechnologyHealth CareMedicalMedical Device

Description

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced it has entered into a definitive agreement to acquire Neovasc Inc. (NASDAQ,TSX:NVCN), a company focused on the minimally invasive treatment of refractory angina.

Company Information

Company

ShockWave Medical, Inc.

Location

5403 BETSY ROSS DRIVE

Santa Clara, California, United States

About

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes.

Related People

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed